Stock Track | GRAIL, Inc. Stock Surges 11.68% on Optimistic Outlook for Cancer Screening Market

Stock Track

2025/02/21

GRAIL, Inc. (GRAL) saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.

The surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund (FFTY), an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer early through a simple blood test.

GRAIL's Galleri multi-cancer early detection test has shown promising results in clinical trials, and its recent partnerships with leading healthcare providers have fueled expectations for widespread adoption and revenue growth. Moreover, the company's Apollo Go robotaxi project is expected to break even in Wuhan in 2024 and be profitable in 2025 as the fleet expands in the city.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1117930013"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1117930013\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1117930013?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-21 14:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117930013","market":"us","top_or_hot":-1,"title":"Stock Track | GRAIL, Inc. Stock Surges 11.68% on Optimistic Outlook for Cancer Screening Market","media":"Stock Track","content":"<p>GRAIL, Inc. (GRAL) saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.</p>\n\n<p>The surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund (FFTY), an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer early through a simple blood test.</p>\n\n<p>GRAIL's Galleri multi-cancer early detection test has shown promising results in clinical trials, and its recent partnerships with leading healthcare providers have fueled expectations for widespread adoption and revenue growth. Moreover, the company's Apollo Go robotaxi project is expected to break even in Wuhan in 2024 and be profitable in 2025 as the fleet expands in the city.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | GRAIL, Inc. Stock Surges 11.68% on Optimistic Outlook for Cancer Screening Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | GRAIL, Inc. Stock Surges 11.68% on Optimistic Outlook for Cancer Screening Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-21 14:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GRAIL, Inc. (GRAL) saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.</p>\n\n<p>The surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund (FFTY), an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer early through a simple blood test.</p>\n\n<p>GRAIL's Galleri multi-cancer early detection test has shown promising results in clinical trials, and its recent partnerships with leading healthcare providers have fueled expectations for widespread adoption and revenue growth. Moreover, the company's Apollo Go robotaxi project is expected to break even in Wuhan in 2024 and be profitable in 2025 as the fleet expands in the city.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GRAL","symbol_name":"GRAIL, Inc.","start_time":0,"source_url":"","article_id":"1117930013","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117930013","pubTimestamp":1740120751,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"GRAIL, Inc.  saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.The surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund , an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer e","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GRAL":"GRAIL, Inc."},"translate_title":"股票追踪GRAIL，Inc.股价因癌症筛查市场前景乐观而飙升11.68%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GRAL":1},"content_text":"GRAIL, Inc. (GRAL) saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.\nThe surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund (FFTY), an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer early through a simple blood test.\nGRAIL's Galleri multi-cancer early detection test has shown promising results in clinical trials, and its recent partnerships with leading healthcare providers have fueled expectations for widespread adoption and revenue growth. Moreover, the company's Apollo Go robotaxi project is expected to break even in Wuhan in 2024 and be profitable in 2025 as the fleet expands in the city.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}